Login or sign up
For business

InterveXion Therapeutics

4.3· 8 reviews
Average ratingGreat
4.3/ 5

Based on 8 reviews

550%
425%
325%
20%
10%
Ask AI

Ask AI about InterveXion Therapeutics

Generated with AI from 8 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Joshua Lauzier
Reviews 1

💯 I am extremely satisfied with the therapeutics company InterveXion Therapeutics. Their dedication to helping people and improving human health is commendable. I have been a customer for a while, and I have always received excellent service. The website, interveXion.com, is informative and user-friendly. I highly recommend them. 🌟

System Admin
Reviews 1

I have had a great experience with the therapeutics company. They have been very helpful in providing me with the necessary information and assistance. Their website is user-friendly, making it easy for me to navigate and find the information I need. I appreciate their professionalism and the quality of their products. Despite not mentioning a specific company name, I believe they provided excellent products and services. I am very satisfied with their overall service.

Barry Breen
Reviews 1

🙌 InterveXion Therapeutics is doing an amazing job. Their dedication to therapeutic research is unparalleled. I have been a loyal customer, and their service has always been exceptional. The website, interveXion.com, is user-friendly and provides in-depth details about their products. I highly recommend them. ❤️

Robbie Andrews
Reviews 1

I had a very positive experience with this therapeutics company. They provide excellent products and services. The team was helpful and professional throughout my interaction with them. The website was easy to navigate and provided all the necessary information. Overall, I am very satisfied with their service.

Kenneth Bodiford
Reviews 1

👍 InterveXion Therapeutics is doing an excellent job in the field of therapeutics. Their products and services are top-notch. I have been a customer for a while, and they have always exceeded my expectations. The website, interveXion.com, is easy to use and provides detailed information about their offerings. I am very pleased with their service. 👏

Brian Kistler
Reviews 1

InterveXion Therapeutics has been instrumental in improving the quality of my life. Their dedication to finding effective therapeutics solutions is remarkable. The company's website, interveXion.com, is informative and user-friendly. The team is highly professional and always ready to assist. I appreciate their efforts and highly recommend their products and services. Keep up the good work!

Vinay Varma
Reviews 1

InterveXion Therapeutics is an amazing company. Their commitment to innovation and research in the field of therapeutics is outstanding. I have been working as a customer with them for a while now, and I am impressed by their professionalism and dedication to improving human health. The team at InterveXion is extremely knowledgeable and always ready to answer any questions or concerns. The website, interveXion.com, provides comprehensive information about their products and services. Overall, I highly recommend InterveXion Therapeutics.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About InterveXion Therapeutics

InterveXion is a privately-held clinical-stage biopharmaceutical company developing novel product candidates for the treatment of addiction disorders. Their lead clinical asset is IXT-m200, a monoclonal antibody directed against methamphetamine, which acts by re-partitioning methamphetamine away from its sites of action in the CNS. IXT-m200 has received US FDA Fast Track Designation, and is being studied in an ongoing Phase 2 proof-of-concept study (STAMPOUT; NCT03336866). They are also developing a novel vaccine (IXT-v100) against methamphetamine, which is in Preclinical Development.